Spots Global Cancer Trial Database for neoplasms malignant
Every month we try and update this database with for neoplasms malignant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase 1 Dose Escalation and Expansion Study of AK117 | NCT04728334 | Neoplasms Malig... | AK117 | 18 Years - 75 Years | Akeso | |
| A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027) | NCT01243762 | Neoplasms Malig... | dalotuzumab MK-0752 ridaforolimus MK-2206 | 18 Years - | Merck Sharp & Dohme LLC | |
| A Study of B1962, a PD-L1/VEGF Bispecific Antibody Fusion Protein, for Advanced Solid Tumors | NCT05650385 | Neoplasms Malig... | B1962 | 18 Years - 75 Years | Tasly Biopharmaceuticals Co., Ltd. | |
| Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging | NCT04721756 | Neoplasms Neoplasms Malig... | 18F-LY3546117 I... PET Scan | 18 Years - | Avid Radiopharmaceuticals | |
| Cancer Survivors Acute Exercise Response 1 | NCT03903848 | Neoplasms Malig... | Exercise | 40 Years - 70 Years | University of Houston | |
| An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK) | NCT01121588 | Neoplasms Malig... | Crizotinib | 15 Years - | Pfizer | |
| A Phase 1 Dose Escalation and Expansion Study of AK117 | NCT04728334 | Neoplasms Malig... | AK117 | 18 Years - 75 Years | Akeso | |
| Thromboembolic Risk Screening in Patients With Cancer and COVID-19 | NCT04616846 | Neoplasms Malig... Covid19 Thromboembolism | Peripheral veno... | 18 Years - | Centre Antoine Lacassagne | |
| Thromboembolic Risk Screening in Patients With Cancer and COVID-19 | NCT04616846 | Neoplasms Malig... Covid19 Thromboembolism | Peripheral veno... | 18 Years - | Centre Antoine Lacassagne | |
| Existential Distress in Patients With Advanced Cancer and Their Caregivers | NCT04600206 | Neoplasms Malig... Carcinoma Palliative Care | Self-report que... | 18 Years - | Universitätsklinikum Hamburg-Eppendorf | |
| Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients | NCT05758571 | Interstitial Pn... Neoplasms Malig... | EGCG | 18 Years - 75 Years | Shandong Cancer Hospital and Institute | |
| Thromboembolic Risk Screening in Patients With Cancer and COVID-19 | NCT04616846 | Neoplasms Malig... Covid19 Thromboembolism | Peripheral veno... | 18 Years - | Centre Antoine Lacassagne | |
| A Study of B1962, a PD-L1/VEGF Bispecific Antibody Fusion Protein, for Advanced Solid Tumors | NCT05650385 | Neoplasms Malig... | B1962 | 18 Years - 75 Years | Tasly Biopharmaceuticals Co., Ltd. | |
| Clinical Application of Super-resolution Ultrasound(SR-US) Imaging in Solid Tumors | NCT06018142 | Neoplasms, Live... Neoplasms Malig... Neoplasm Metast... Ultrasound Microvessels | 18 Years - 80 Years | Chinese PLA General Hospital | ||
| Cancer Survivors Acute Exercise Response 1 | NCT03903848 | Neoplasms Malig... | Exercise | 40 Years - 70 Years | University of Houston | |
| Existential Distress in Patients With Advanced Cancer and Their Caregivers | NCT04600206 | Neoplasms Malig... Carcinoma Palliative Care | Self-report que... | 18 Years - | Universitätsklinikum Hamburg-Eppendorf |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
